CYP19A1 and cancer: We concluded that the following factors may drive breast cancer recurrence in postmenopausal women: advanced cancer stage at diagnosis (stage III most frequently, but also stage II), luminal B molecular subtype, upper outer quadrant localization of the primary BC tumor, mastectomy, and use of aromatase inhibitors.